OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeted protein degradation in cancers: Orthodox PROTACs and beyond
Jin Li, Xinxin Chen, Aiping Lü, et al.
The Innovation (2023) Vol. 4, Iss. 3, pp. 100413-100413
Open Access | Times Cited: 32

Showing 26-50 of 32 citing articles:

DNA Nanotechnology for Application in Targeted Protein Degradation
Yang Xiao, Xinyi Guo, Weiwei Zhang, et al.
ACS Biomaterials Science & Engineering (2024)
Closed Access

RNF2 promotes chondrosarcoma progression by regulating ubiquitination and degradation of CBX7
Yue Wu, Zheng Huang, Ping Luo, et al.
Cancer & Metabolism (2024) Vol. 12, Iss. 1
Open Access

Protacs in cancer therapy: mechanisms, design, clinical trials, and future directions
Akash Vikal, Rashmi Maurya, Brij Bihari Patel, et al.
Drug Delivery and Translational Research (2024)
Closed Access

Nanotechnology‐Enabled Targeted Protein Degradation for Cancer Therapeutics
Wutong Zhao, Yongbin Jiang, Xiufen Li, et al.
Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology (2024) Vol. 16, Iss. 6
Closed Access

Discovery of a Natural Ent-Kaurene Diterpenoid Oridonin as an E3 Ligase Recruiter for PROTACs
Jie Huang, Xuekun Fu, Fang Qiu, et al.
Journal of the American Chemical Society (2024)
Closed Access

Highlights from AACR 2023 Annual Meeting
Haitao Wang
The Innovation Medicine (2023) Vol. 1, Iss. 1, pp. 100003-100003
Open Access | Times Cited: 1

Integration of signaling pathway and bromodomain and extra-terminal domain inhibition for the treatment of mutant Kirsten rat sarcoma viral oncogene homolog cancer
Gerhard Hamilton, Sandra Stickler, Barbara Rath
Exploration of Targeted Anti-tumor Therapy (2023), pp. 1027-1038
Open Access | Times Cited: 1

Previous Page - Page 2

Scroll to top